{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T12:44:11Z","timestamp":1776689051826,"version":"3.51.2"},"reference-count":46,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1016\/j.cyto.2009.09.014","type":"journal-article","created":{"date-parts":[[2009,10,30]],"date-time":"2009-10-30T08:36:59Z","timestamp":1256891819000},"page":"163-170","source":"Crossref","is-referenced-by-count":41,"title":["Wide-spectrum profile of inflammatory mediators in the plasma and scales of patients with psoriatic disease"],"prefix":"10.1016","volume":"49","author":[{"given":"Irina","family":"Deeva","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serena","family":"Mariani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"De Luca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valeria","family":"Pacifico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Leoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Desanka","family":"Raskovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zaira","family":"Kharaeva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liudmila","family":"Korkina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saveria","family":"Pastore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2009.09.014_bib1","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0140-6736(07)61128-3","article-title":"Pathogenesis and clinical features of psoriasis","volume":"370","author":"Griffiths","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.cyto.2009.09.014_bib2","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1038\/sj.jid.5701213","article-title":"Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells","volume":"128","author":"Lowes","year":"2008","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.cyto.2009.09.014_bib3","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1056\/NEJMra0804595","article-title":"Psoriasis","volume":"361","author":"Nestle","year":"2009","journal-title":"New Engl J Med"},{"key":"10.1016\/j.cyto.2009.09.014_bib4","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.clindermatol.2006.07.006","article-title":"Psoriasis and psoriatic arthritis: clinical features and disease mechanisms","volume":"24","author":"Myers","year":"2006","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.cyto.2009.09.014_bib5","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1111\/j.1365-4632.2008.03753.x","article-title":"A comparison between BSA, PASI, PLASI and SAPASI as measures of disease severity and improvement by therapy in patients with psoriasis","volume":"47","author":"Henseler","year":"2008","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.cyto.2009.09.014_bib6","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1159\/000083509","article-title":"The psoriasis area and severity index is the adequate criterion to define severity in chronic plaque-type psoriasis","volume":"210","author":"Schmitt","year":"2005","journal-title":"Dermatology"},{"key":"10.1016\/j.cyto.2009.09.014_bib7","first-page":"1443","article-title":"Biological biomarkers in psoriatic disease","volume":"35","author":"De Vlam","year":"2008","journal-title":"J Rheumatol"},{"key":"10.1016\/j.cyto.2009.09.014_bib8","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s002960050111","article-title":"Serum levels of IL-10, IL-6, IL-1ra and sIL-2R in patients with psoriatic arthritis","volume":"19","author":"Elkayam","year":"2000","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.cyto.2009.09.014_bib9","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/j.1365-2133.2005.06648.x","article-title":"Cytokine profiles during infliximab monotherapy in psoriasis arthritis","volume":"153","author":"Mastroianni","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.cyto.2009.09.014_bib10","doi-asserted-by":"crossref","unstructured":"Zalewska A, Glowacka E, Wyczolkowka J, Tch\u00f2rzewski H, Narbutt J, Sysa-Jedrzejowska A. Interleukin 6 and 8 levels in plasma and fibroblasts cultures in psoriasis. Mediators Inflamm 2006, ID 81767.","DOI":"10.1155\/MI\/2006\/81767"},{"key":"10.1016\/j.cyto.2009.09.014_bib11","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1067\/mai.2001.114707","article-title":"Keratinocytes from patients with atopic dermatitis and psoriasis show a distinct chemokine production profile in response to T cell-derived cytokines","volume":"107","author":"Giustizieri","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.cyto.2009.09.014_bib12","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/1523-1747.ep12494196","article-title":"Interleukin-1 receptor antagonist production by human keratinocytes","volume":"98","author":"Bigler","year":"1992","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.cyto.2009.09.014_bib13","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1091\/mbc.E03-05-0352","article-title":"Mechanism of human dermal fibroblast migration driven by type I collagen and platelet-derived growth factor BB","volume":"15","author":"Li","year":"2004","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.cyto.2009.09.014_bib14","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1152\/physrev.1999.79.4.1283","article-title":"Mechanism of action and in vivo role of platelet-derived growth factor","volume":"79","author":"Heldin","year":"1999","journal-title":"Physiol Rev"},{"key":"10.1016\/j.cyto.2009.09.014_bib15","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1111\/1523-1747.ep12476485","article-title":"Increased dermal expression of platelet-derived growth factor receptors in growth-activated skin wounds and psoriasis","volume":"96","author":"Krane","year":"1991","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.cyto.2009.09.014_bib16","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1172\/JCI116636","article-title":"Human keratinocytes are a major source of cutaneous platelet-derived growth factor","volume":"92","author":"Ansel","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cyto.2009.09.014_bib17","first-page":"1507","article-title":"Fibroblast function in psoriasi arthritis. II. Increased expression of beta platelet derived growth factor receptors and increate production of growth factor and cytokines","volume":"21","author":"Espinoza","year":"1994","journal-title":"J Rheumatol"},{"key":"10.1016\/j.cyto.2009.09.014_bib18","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1080\/09629350310001619753","article-title":"Simultaneous measurement of multiple Th1 and Th2 serum cytokines in psoriasis and correlation with disease severity","volume":"12","author":"Jacob","year":"2003","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.cyto.2009.09.014_bib19","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1155\/MI.2005.273","article-title":"Serum levels of TNF-alpha, IFN-gamma, IL-6, IL-8, IL-12, IL-17 and IL-18 in patients with active psoriasis and correlation with disease severity","volume":"5","author":"Arican","year":"2005","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.cyto.2009.09.014_bib20","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.jaad.2008.02.039","article-title":"Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics","volume":"58","author":"Menter","year":"2008","journal-title":"J Am Acad Dermatol"},{"issue":"Suppl. 2","key":"10.1016\/j.cyto.2009.09.014_bib21","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1365-2133.2008.08779.x","article-title":"Long-term prognosis in patients with psoriasis","volume":"159","author":"Gulliver","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.cyto.2009.09.014_bib22","first-page":"563","article-title":"Psoriasis and the metabolic syndrome","volume":"7","author":"Gottlieb","year":"2008","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.cyto.2009.09.014_bib23","doi-asserted-by":"crossref","unstructured":"National Institute of Health, Third report of the National Cholesterol Education Program Expert Panel on detection, evaluation and treatment of high blood cholesterol in adults [Adult Panel Treatment Panel III]. Executive summary. NIH Pubbl No. 01-3670, Bethesda, MD: National Institute of Health, National Heart, Lung, and Blood Institute; 2001.","DOI":"10.1001\/jama.285.19.2486"},{"key":"10.1016\/j.cyto.2009.09.014_bib24","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1365-2133.2007.07986.x","article-title":"Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based case-control study","volume":"157","author":"Gisondi","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.cyto.2009.09.014_bib25","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1080\/713773647","article-title":"Platelet chemokines and chemokine receptors: linking hemostasis, inflammation, and host defense","volume":"10","author":"Gear","year":"2003","journal-title":"Microcirculation"},{"key":"10.1016\/j.cyto.2009.09.014_bib26","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1479-5876-4-40","article-title":"Comparison of proteomic profiles of serum, plasma, and modified media supplements used for cell culture and expansion","volume":"4","author":"Ayache","year":"2006","journal-title":"J Translat Med"},{"key":"10.1016\/j.cyto.2009.09.014_bib27","doi-asserted-by":"crossref","first-page":"3262","DOI":"10.4049\/jimmunol.171.6.3262","article-title":"Cytokine milieu of atopic dermatitis, as compared to psoriasis, skin prevents induction of innate immune response genes","volume":"171","author":"Nomura","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2009.09.014_bib28","first-page":"309","article-title":"Keratinocytes as targets for interleukin-10-related cytokines: a putative role in the pathogenesis of psoriasis","volume":"16","author":"Boniface","year":"2005","journal-title":"Eur Cytokine Netw"},{"key":"10.1016\/j.cyto.2009.09.014_bib29","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1189\/jlb.0408249","article-title":"Comprehensive biomarker monitoring in cytokine therapy: heterogeneous, time-dependent, and persisting immune effects of interleukin-10 application in psoriasis","volume":"85","author":"D\u00f6cke","year":"2009","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.cyto.2009.09.014_bib30","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1172\/JCI115896","article-title":"Interleukin-1 receptor antagonist in normal and psoriatic skin","volume":"90","author":"Hammerberg","year":"1992","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cyto.2009.09.014_bib31","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1002\/eji.1830250623","article-title":"Enhanced production of biologically active interleukin-1 alpha and interleukin-1 beta by psoriatic epidermal cells ex vivo: evidence of increased cytosolic interleukin-1 beta levels and facilitated interleukin-1 release","volume":"25","author":"Debets","year":"1995","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.cyto.2009.09.014_bib32","doi-asserted-by":"crossref","first-page":"121S","DOI":"10.1111\/1523-1747.ep12874991","article-title":"Interleukin-1 and interleukin-6 in psoriasis","volume":"95","author":"Prens","year":"1990","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.cyto.2009.09.014_bib33","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/BF00371814","article-title":"In situ expression of messenger RNA of interleukin-1 and interleukin-6 in psoriasis: interleukin-6 involved in formation of psoriatic lesions","volume":"283","author":"Ohta","year":"1991","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.cyto.2009.09.014_bib34","first-page":"129","article-title":"Cellular localization of interleukin-8 and its inducer, tumor necrosis factor-alpha in psoriasis","volume":"138","author":"Nickoloff","year":"1991","journal-title":"Am J Pathol"},{"key":"10.1016\/j.cyto.2009.09.014_bib35","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/j.1365-2249.1993.tb03457.x","article-title":"Localization of tumour necrosis factor-alpha (TNF-alpha) and its receptors in normal and psoriatic skin: epidermal cells express the 55-kD but not the 75-kD TNF receptor","volume":"94","author":"Kristensen","year":"1993","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.cyto.2009.09.014_bib36","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1046\/j.1523-1747.1998.00419.x","article-title":"Identification and quantitation of interferon-gamma producing T cells in psoriatic lesions: localization to both CD4+ and CD8+ subsets","volume":"111","author":"Szabo","year":"1998","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.cyto.2009.09.014_bib37","first-page":"1092","article-title":"Th17 cytokines interleukin (IL)-17 and IL-22 modulate distinct inflammatory and keratinocyte-response pathways","volume":"159","author":"Nograles","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.cyto.2009.09.014_bib38","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1084\/jem.20030451","article-title":"Increased expression of interleukin 23 p19 and p40 in lesional skin of patients with psoriasis vulgaris","volume":"199","author":"Lee","year":"2004","journal-title":"J Exp Med"},{"key":"10.1016\/j.cyto.2009.09.014_bib39","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.4049\/jimmunol.176.3.1908","article-title":"In vitro and in situ expression of IL-23 by keratinocytes in healthy skin and psoriasis lesions: enhanced expression in psoriatic skin","volume":"176","author":"Piskin","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2009.09.014_bib40","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s11926-007-0075-1","article-title":"Pathophysiology of psoriasis: recent advances on IL-23 and Th17 cytokines","volume":"9","author":"Fitch","year":"2007","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.cyto.2009.09.014_bib41","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S0923-1811(96)00539-7","article-title":"Localization of monocyte chemotactic and activating factor (MCAF\/MCP-1) in psoriasis","volume":"13","author":"Deleuran","year":"1996","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.cyto.2009.09.014_bib42","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/000155599750011615","article-title":"Upregulation of RANTES in psoriatic keratinocytes: a possible pathogenic mechanism for psoriasis","volume":"79","author":"Raychaudhuri","year":"1999","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.cyto.2009.09.014_bib43","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1084\/jem.168.3.941","article-title":"Detection of a gamma interferon-induced protein IP-10 in psoriatic plaques","volume":"168","author":"Gottlieb","year":"1988","journal-title":"J Exp Med"},{"key":"10.1016\/j.cyto.2009.09.014_bib44","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1056\/NEJMra041320","article-title":"Psoriasis","volume":"352","author":"Sch\u00f6n","year":"2005","journal-title":"New Engl J Med"},{"key":"10.1016\/j.cyto.2009.09.014_bib45","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/j.1365-2567.2007.02782.x","article-title":"Microbicidal protein psoriasin is a multifunctional modulator of neutrophil activation","volume":"124","author":"Zheng","year":"2008","journal-title":"Immunology"},{"key":"10.1016\/j.cyto.2009.09.014_bib46","doi-asserted-by":"crossref","unstructured":"Biomarkers Definition Working Group. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther 2001;69:89\u201395.","DOI":"10.1067\/mcp.2001.113989"}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466609008357?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466609008357?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T14:01:20Z","timestamp":1558620080000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466609008357"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2]]},"references-count":46,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["S1043466609008357"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2009.09.014","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2010,2]]}}}